Lorenz H. Trumper
Expertise in
12
conditions

Lorenz H. Trumper

Robert Koch Str. 40, 
Goettingen, NI, DE 
Expertise in
12
conditions
Robert Koch Str. 40, 
Goettingen, NI, DE 

Overview

Lorenz Trumper practices practicing medicine in Goettingen, Germany.

Mr. Trumper is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, B-Cell Lymphoma, Burkitt Lymphoma, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 149 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Robert Koch Str. 40, Goettingen, NI 37075, Germany
Other Locations
Robert Koch Str. 42, Goettingen, NI 37077, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Obinutuzumab in Marginal Zone Lymphoma (OLYMP-1)
Obinutuzumab in Marginal Zone Lymphoma (OLYMP-1)
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug
Study Drug: Obinutuzumab
Study Phase: Phase 2
Phase 3 Multi-center Randomized Study to Compare Efficacy and Safety of Romidepsin CHOP (Ro-CHOP) Versus CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma
Phase 3 Multi-center Randomized Study to Compare Efficacy and Safety of Romidepsin CHOP (Ro-CHOP) Versus CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drugs: Romidepsin, CHOP
Study Phase: Phase 3
Subcutaneous Rituximab and Intravenous Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients (Slow Go) With Aggressive CD20-positive B-cell
Subcutaneous Rituximab and Intravenous Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients (Slow Go) With Aggressive CD20-positive B-cell
Enrollment Status: Completed
Publish Date: December 31, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

149 Total Publications

AI for prognostic assessment of diffuse large B-cell lymphoma using H&E whole-slide images.
AI for prognostic assessment of diffuse large B-cell lymphoma using H&E whole-slide images.
Journal: HemaSphere
Published: April 08, 2026

Frequently Asked Questions about Lorenz H. Trumper

Is Lorenz H. Trumper a top-rated expert for Non-Hodgkin Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Lorenz H. Trumper is classified as an Elite expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lorenz H. Trumper participate in research or clinical trials?

Yes. Lorenz H. Trumper has published 149 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Lorenz H. Trumper's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Trumper's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile